Clinical Application of RDW,HCY and LP (a) in High Blood Pressure and Combined Coronary Heart Disease
10.3969/j.issn.1671-7414.2017.04.022
- VernacularTitle:RDW,HCY和LP(a)在高血压及冠心病中的临床应用
- Author:
Xiayan LIU
;
Anyun YU
;
Peifang YU
;
Ya WANG
- Keywords:
red cell distribution width;
homocysteine;
lipoprotein (a);
coronary heart disease
- From:
Journal of Modern Laboratory Medicine
2017;32(4):80-82,86
- CountryChina
- Language:Chinese
-
Abstract:
Objective Understanding of red blood cell distribution width (RDW-CV),blood homocysteine (HCY),lipoprotein a [LP(a)] a merger with high blood pressure and high blood,coronary heart disease (CHD) relevance and explore its clinical application value in CHD.Methods 563 cases of patients with high blood pressure were enrolled,which divided into 62 cases of primary hypertension,501 cases of hypertension combined with coronary heart disease,according to the results of coronary angiography.141 normal cases were chosen as control group.Compared the three groups of RDW-CV,HCY and LP (a) level,the group of coronary artery disease was divided into Ⅰ,Ⅱ,Ⅲ and Ⅳ,and compared the RDW-CV level of each group,and the correlation between RDW and cardiac function was analyzed.Results ①Heart disease groups RDW-CV,LP (a) and HCY (13.25 ± 1.22％,17.82 ± 8.36 μmol/L,172.05 ± 122.32 mg/L) were higher than blood pressure groups (12.98 ± 0.57 ％,14.35 ± 6.36 μ mol/L,124.49 ± 75.88 mg/L) and normal control group (11.41 ± 2.85 ％,11.41 ± 2.85 μmol/L,71.07±27.55 mg/L,P＜0.05).②RDW-CV and HCY were positively correlated with the mental function classification (r=0.461,0.1970;P=0.000,0.032).③The area under the ROC curve was the order of the diagnostic value:HCY ＞LP(a) ＞RDW-CV.LP(a) sensitivity was 82.5 ％ and specificity was 31.7 ％.RDW-CV sensitivity was 48.8 ％ and specificity was 22.2 ％.Conclusion High levels of RDW-CV,HCY,and LP(a) were closely related to the occurrence of coronary heart disease;RDW-CV and HCY were related to the severity of coronary heart disease and cardiac function,and could be a potential biomarker for the development of cardiac function of coronary heart disease.
